Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Neoplasm Metastasis 8Esophageal Neoplasms 8Carcinoma, Hepatocellular 7Melanoma 6Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Rectal Neoplasms 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Breast Neoplasms, Male 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Pleural Mesothelial Neoplasm 1

Interventions

trilaciclib 1durvalumab 1Sodium Chloride 1Probiotics 1Immunotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Immunotherapy × 1 year × Clear all
NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡